Search for: "Eli Lilly " Results 1921 - 1940 of 2,131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Mar 2018, 2:35 pm by Law Offices of Jeffrey S. Glassman
For instance, earlier this year Eli Lilly & Co. reached a settlement over federal product liability lawsuits pending for damage caused by its testosterone drug Axiron. [read post]
11 Dec 2009, 5:00 am
Eli Lilly & Co., 751 P.2d 923, 929-32 (Cal. 1988) (all sorts of stuff omitted to make the block quote even this short). [read post]
21 Oct 2014, 9:03 am by Dennis Crouch
A number of Amici supported the petition, including BIO, Pfizer, Eli Lilly, PhRMA, IPO, and Merck. [read post]
24 Mar 2011, 4:40 pm by James Hamilton
He asked COSO to consider including it in the updated framework.Noting the Sarbanes-Oxley Sec. 407 requirement that companies disclose if they have a financial expert on the audit committee, SAG member, and Eli Lilly & Company Chief Accounting Officer, Arnold Hanish said that there is a need to beef up financial experts on boards. [read post]
28 Sep 2011, 2:00 am by Stefanie Levine
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
18 Feb 2011, 4:11 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
11 Aug 2010, 10:30 pm
Sprint Nextel waived any claimed error associated with the "connecting circuitry" structure: Here, as in Eli Lilly & Co. v. [read post]
2 Dec 2015, 2:13 pm by Robert B. Milligan and Amy Abeloff
., Corning Incorporated, Eli Lilly and Company, General Electric, Honda, IBM, Illinois Tool Works Inc., Intel, The Intellectual Property Owners Association (IPO), International Fragrance Association, North America, Johnson & Johnson, Medtronic, Micron, National Alliance for Jobs and Innovation (NAJI), National Association of Manufacturers (NAM), NIKE, Pfizer, Philips, The Procter & Gamble Company, SAS, Siemens Corporation, Software & Information Industry Association… [read post]
15 Jun 2012, 10:38 am by Eric
Eli Lilly & Co., 233 F.3d at 465 (noting that the defendant's references to the plaintiff's trademark (PROZAC®) in its website source codes was evidence of wrongful intent to divert Internet users searching for information on PROZAC® to the defendant's website). [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas,… [read post]
20 May 2016, 8:58 am by Brian Cordery
It is necessary to avoid a mechanistic approach, and to compare the disclosures of the application as filed and the patent, through the eyes of the skilled person, in order to answer the overall question of whether the skilled person would learn new technical subject matter which was not disclosed in the application” Novelty In relation to the first citation, patent application “WO885”, Carr J applied Dr Reddy’s v Eli Lilly [2010] and considered whether the… [read post]
20 Nov 2011, 9:39 pm
If this Kat were not busying himself tomorrow (Tuesday, that is) in chairing the IP Finance seminar on FRAND licensing, he would be beetling over to the very comfy London office of Allen & Overy, in Bishops Square, to enjoy a rapid response seminar on the UK Supreme Court's extremely recent ruling in Human Genome Sciences v Eli Lilly (noted by the IPKat here). [read post]
27 Jul 2011, 1:01 am by Marie Louise
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog)   Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]
8 May 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
7 Jun 2011, 8:51 am by Michelle Yeary
Eli Lilly & Co., 2010 WL 348276, at *11 (E.D.N.Y. [read post]
27 Oct 2010, 3:38 am by Kelly
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
25 Feb 2012, 10:04 am by Schachtman
Eli Lilly & Co., 2009 WL 2208570 (D.N.M.) [read post]